Inventiva S.A.(IVA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

IVA Inventiva S.A.

Post-Mkt 06-16 18:34:15 EDT

3.58

-0.18

-4.79%

盘后3.58

+0.000.00%

16:10 EDT

High3.73	Low3.56	Vol474.83K
Open3.73	D1 Closing3.76	Amplitude4.52%
Mkt Cap844.88M	Tradable Cap655.14M	Total Shares236.00M
T/O1.71M	T/O Rate0.26%	Tradable Shares183.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"IVA","market":"US","secType":"STK","nameCN":"Inventiva S.A.","latestPrice":3.58,"timestamp":1781640000000,"preClose":3.76,"halted":0,"volume":474831,"hourTrading":{"tag":"盘后","latestPrice":3.58,"preClose":3.58,"latestTime":"16:10 EDT","volume":585,"amount":2096.3198295,"timestamp":1781640604659,"change":0,"changeRate":0,"amplitude":0.002793},"delay":0,"changeRate":-0.047872340425531845,"floatShares":183000000,"shares":236000000,"eps":-2.230832,"marketStatus":"Post-Mkt","change":-0.18,"latestTime":"06-16 18:34:15 EDT","open":3.73,"high":3.73,"low":3.56,"amount":1709356,"amplitude":0.045213,"askPrice":4.04,"askSize":100,"bidPrice":3.21,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.230832,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1781654400000},"marketStatusCode":4,"adr":0,"adrRate":1,"listingDate":1594353600000,"exchange":"NASDAQ","adjPreClose":3.76,"preHourTrading":{"tag":"盘前","latestPrice":3.71,"preClose":3.76,"latestTime":"09:26 EDT","volume":2544,"amount":9434.719104,"timestamp":1781616390594,"change":-0.05,"changeRate":-0.013298,"amplitude":0.018617},"postHourTrading":{"tag":"盘后","latestPrice":3.58,"preClose":3.58,"latestTime":"16:10 EDT","volume":585,"amount":2096.3198295,"timestamp":1781640604659,"change":0,"changeRate":0,"amplitude":0.002793},"volumeRatio":0.623156,"impliedVol":1.0011,"impliedVolPercentile":0.4091},"requestUrl":"/m/hq/s/IVA","defaultTab":"news","newsList":[{"id":"2643270086","title":"Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), Rhythm Pharmaceuticals (RYTM) and Belite Bio, Inc. ADR (BLTE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2643270086","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643270086?lang=en_us&edition=fundamental","pubTime":"2026-06-15 19:10","pubTimestamp":1781521813,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Inventiva (IVA), Rhythm Pharmaceuticals (RYTM) and B...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-inventiva-iva-rhythm-pharmaceuticals-rytm-and-belite-bio-inc-adr-blte-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-inventiva-iva-rhythm-pharmaceuticals-rytm-and-belite-bio-inc-adr-blte-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4581","BK4137","BK4007","HCSG","XLV","LABU","BK4585","LU0128526141.USD","IVA","RYTM","BK4139","LU0029874061.USD","XBI","BLTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642924004","title":"Press Release: Statement of Total Voting Rights and Shares Forming The Company's Share Capital as of May 22, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2642924004","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642924004?lang=en_us&edition=fundamental","pubTime":"2026-06-10 04:00","pubTimestamp":1781035200,"startTime":"0","endTime":"0","summary":"Number of Shares    Total Voting Rights,  Total Voting Rights,May 22, 2026           209 007 475           218 082 368           218 082 368. basis for calculating threshold crossings. In accordance with Article. 223-11 of the AMF General Regulations, this number is calculated on the. basis of all shares to which voting rights are attached, including those. voting rights is calculated without taking into account shares for which. voting rights have been suspended, i.e. treasury shares (including shares. purchased under the liquidity contract). It is released in order to. Inventiva is a clinical-stage biopharmaceutical company focused on the research and development of an orally administered small molecule for the treatment of patients with MASH. The Company is currently evaluating lanifibranor, a novel pan-PPAR agonist, in the NATiV3 pivotal Phase 3 clinical trial for the treatment of adult patients with MASH, a common and progressive chronic liver disease.Media Relations Pascaline Cle","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVA","BK4139","TSS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642401492","title":"Press Release: Combined General Meeting of June 30, 2026 - Availability of the Preparatory Documents","url":"https://stock-news.laohu8.com/highlight/detail?id=2642401492","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642401492?lang=en_us&edition=fundamental","pubTime":"2026-06-10 04:00","pubTimestamp":1781035200,"startTime":"0","endTime":"0","summary":"Daix , New York City , June 9,2026 -- Inventiva  , a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis , today announced the availability of the preparatory documents for the Combined General Meeting of June 30, 2026.Shareholders are invited to participate in the Combined General Meeting that will be held on June 30, 2026 at 2 p.m. at Htel Villa M, 24 -- 30 Boulevard Pasteur, 75015 Paris .In accordance with Articles R. 225-83 and R. 225-89 of the French Commercial Code, documents that must be available for the shareholders for the","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641748978","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Apogee Therapeutics (APGE), Inventiva (IVA) and Roche Holding AG (OtherRHHVF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2641748978","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641748978?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:40","pubTimestamp":1780918856,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Apogee Therapeutics (APGE), Inventiva (IVA) and Ro...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-apogee-therapeutics-apge-inventiva-iva-and-roche-holding-ag-otherrhhvf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-apogee-therapeutics-apge-inventiva-iva-and-roche-holding-ag-otherrhhvf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APGE","HCSG","LU0029874061.USD","LU0053671581.USD","BK4139","BK4210","BK4581","IVA","XLV","AG","BK4588","BK4137","LABU","XBI","LU0128526141.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640687153","title":"Inventiva (IVA) Receives a Buy from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2640687153","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640687153?lang=en_us&edition=fundamental","pubTime":"2026-06-04 16:36","pubTimestamp":1780562196,"startTime":"0","endTime":"0","summary":"Barclays analyst Eliana Merle maintained a Buy rating on Inventiva today and set a price target of $18.00. Merle covers the Healthcare sector, focu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/inventiva-iva-receives-a-buy-from-barclays-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/inventiva-iva-receives-a-buy-from-barclays-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4581","IVA","XLV","BK4588","LABU","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640582912","title":"Inventiva files automatic mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2640582912","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640582912?lang=en_us&edition=fundamental","pubTime":"2026-06-02 18:26","pubTimestamp":1780396000,"startTime":"0","endTime":"0","summary":"06:12 EDT Inventiva (IVA) files automatic mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving break...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inventiva-files-automatic-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inventiva-files-automatic-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633021579","title":"eGain Launches AI Agent IVA to Deliver Accurate, Conversational Customer Service","url":"https://stock-news.laohu8.com/highlight/detail?id=2633021579","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633021579?lang=en_us&edition=fundamental","pubTime":"2026-05-06 15:56","pubTimestamp":1778054160,"startTime":"0","endTime":"0","summary":"Intelligent Virtual Agent brings trusted knowledge to every customer conversationSUNYVALE, Calif., May  06, 2026 (GLOBE NEWSWIRE) -- eGain (NASDAQ: EGAN) today announced the launch of AI Agent IVA, an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/06/3288531/0/en/eGain-Launches-AI-Agent-IVA-to-Deliver-Accurate-Conversational-Customer-Service.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","AIPO","BK4543","BK4585","CHAT","AIYY","BK4528","IVA","BK4139","BK4551","BK4587","EGAN","AI","AGIX","BK4588","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629079968","title":"Inventiva Names Malkomes as CFO Ahead of Lanifibranor Phase 3 Readout","url":"https://stock-news.laohu8.com/highlight/detail?id=2629079968","media":"Dow Jones","labels":["executive","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629079968?lang=en_us&edition=fundamental","pubTime":"2026-04-23 06:51","pubTimestamp":1776898260,"startTime":"0","endTime":"0","summary":"Inventiva appointed Axel-Sven Malkomes as its new chief financial officer ahead of the company's planned readout of Phase 3 trial results for lanifibranor, a liver-disease treatment.Current Chief Financial Officer Jean Volatier will stay on as the biopharmaceutical company's executive vice president, finance & corporate social responsibility.Malkomes most recently served as CFO of CureVac. He has also served as CFO of Cardio, helping lead its acquisition by Novo Nordisk, as well as CFO and chief business officer at Midigene.The company also named Susan Coles as its chief legal officer and Pamela Herbster as its chief people officer.Coles was previously head of legal and finance for Vivet Therapeutics. She also served two stints as Inventiva's general counsel, from 2012 to 2014 and from 2019 to 2021.Herbster previously led human resources and business operations at Sage Therapeutics.They are joining Inventiva in advance of its readout of trial results for lanifibranor, a treatment for m","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Inventiva Names Malkomes as CFO Ahead of Lanifibranor Phase 3 Readout","news_tag":"executive,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629020001","title":"Inventiva CFO Jean Volatier to switch roles, Axel-Sven Malkomes to succeed","url":"https://stock-news.laohu8.com/highlight/detail?id=2629020001","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629020001?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:16","pubTimestamp":1776888971,"startTime":"0","endTime":"0","summary":"Inventiva (IVA) announced three new members of its leadership team: Axel-Sven Malkomes as CFO, Susan Coles as chief legal officer, and Pamela Herbs...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inventiva-cfo-jean-volatier-to-switch-roles-axel-sven-malkomes-to-succeed-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inventiva-cfo-jean-volatier-to-switch-roles-axel-sven-malkomes-to-succeed-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627214637","title":"AcadeMedia Buys Dutch IVA Business School to Bolster Adult Education Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2627214637","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627214637?lang=en_us&edition=fundamental","pubTime":"2026-04-16 22:45","pubTimestamp":1776350713,"startTime":"0","endTime":"0","summary":"AcadeMedia AB ( ($SE:ACAD) ) has shared an update. AcadeMedia, Northern Europe’s largest private education provider, is expanding its Dutch footpri...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/academedia-buys-dutch-iva-business-school-to-bolster-adult-education-push?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/academedia-buys-dutch-iva-business-school-to-bolster-adult-education-push?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGXZ58947870.SGD","BK4548","LU0516423091.SGD","LU1048588211.SGD","LU2125910500.SGD","IE0034224299.USD","IVA","SG9999002604.SGD","LU0210637038.USD","LU0823039010.USD","BK4503","BK4085","SG9999013486.USD","SG9999002414.USD","LU1861220207.SGD","LU0048573645.USD","IE0001KFT4U8.USD","LU0516422952.EUR","LU0345776255.USD","LU0289960550.SGD","LU2125910849.SGD","SG9999002679.SGD","LU0823038988.USD","LU0737861269.HKD","LU1861217088.USD","LU0345775950.USD","LU0261945553.USD","LU1242518931.SGD","BK4551","LU0589944569.HKD","LU0499858438.USD","LU2065170008.USD","LU1242518857.USD","SG9999014484.SGD","LU2238330802.EUR","BK4566","LU2065171402.SGD","LU2543165471.USD","LU0516423174.USD","SG9999013478.USD","LU2008162690.USD","LU0441851309.USD","SG9999013460.SGD","LU0348788117.USD","BK4139","SG9999002620.SGD","LU0532188223.SGD","LU0516422366.SGD","LU0516422440.USD","LU0264606111.USD","LU1770036033.HKD","LU2065171311.SGD","BK4581","LU0499858602.USD","0RHN.UK","SG9999001135.SGD","SG9999014492.USD","IE00BD6J9T35.USD","BK4554","BK4588","LU0251143029.SGD","BK4535","LU0572939691.SGD","LU1839390173.USD","LU2360107671.USD","LU2152927971.USD","IE0031814969.USD","LU2177674079.SGD","SG9999006266.SGD","SG9999004360.SGD","LU0175139822.USD","BK4585","LU2045819591.USD","SG9999002406.SGD","LU0979878070.USD","LU0572940350.SGD","SG9999005177.SGD","BK4220","LU2065169927.USD","LU0072462343.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625993257","title":"Analysts Are Bullish on These Healthcare Stocks: Inventiva (IVA), Stereotaxis (STXS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2625993257","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625993257?lang=en_us&edition=fundamental","pubTime":"2026-04-07 18:50","pubTimestamp":1775559056,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Inventiva (IVA), Stereotaxis (STXS) and Merck & Comp...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-inventiva-iva-stereotaxis-stxs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-inventiva-iva-stereotaxis-stxs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2023250843.SGD","IE000M9KFDE8.USD","LU1974910355.USD","LU2125154935.USD","LU1699723380.USD","LU0208291251.USD","LU0980610538.SGD","IE00B4R5TH58.HKD","BK4007","LU0029874061.USD","LU0122379950.USD","LU1037948541.HKD","LU1989772923.USD","LU2089984988.USD","SGXZ57979304.SGD","LU2361044865.SGD","BK4534","STXS","IE00BSNM7G36.USD","SG9999013999.USD","LU2112291526.USD","SG9999002224.SGD","LU0265550946.USD","LU0648001328.SGD","LU1037948897.HKD","LU2468319806.SGD","LU1066051811.HKD","LU0868494617.USD","IE00B2B36J28.USD","LU1585245621.USD","LU1061106388.HKD","LU0203345920.USD","LU1066053197.SGD","LU0098860793.USD","LU1023059063.AUD","LU0289739699.SGD","BK4137","BK4585","LU0058720904.USD","LU0985320562.USD","SG9999014575.USD","LU1934455863.HKD","LU2360032135.SGD","BK4559","IE00BJJMRZ35.SGD","LU1093756325.SGD","LU1934455194.USD","SG9999014542.SGD","SG9999014567.USD","SG9999001176.SGD","LU1571399168.USD","IE00BBT3K403.USD","LU1066051225.USD","LU1983299246.USD","LU0320765489.SGD","LU0942090050.USD","LU1941712264.USD","IE00BLSP4239.USD","LU0211331839.USD","IE0002141913.USD","LU2324357040.USD","LU1917777945.USD","BLSG","LU0106261372.USD","LU2023250504.SGD","SG9999001440.SGD","LU1057294990.SGD","LABU","LU0868494708.USD","LU0265550359.USD","BK4516","LU0861579265.USD","BK4581","LU0965509101.SGD","LU1093756168.USD","BK4112","BK4588","IE00BFTCPJ56.SGD","LU0130102774.USD","LU0130517989.USD","LU1116320901.HKD","LU0070302665.USD","LU1116320737.USD","IE00B1BXHZ80.USD","LU2106854487.HKD","LU1430594728.SGD","LU1941712348.USD","LU0203347892.USD","LU1035773651.USD","LU0965508806.USD","BK4550","LU0128526141.USD","LU1066051498.USD","LU1989772840.SGD","LU2125154778.USD","LU2361044949.HKD","IE00BJT1NW94.SGD","SG9999001176.USD","LU0320765646.SGD","MRK","SG9999014559.SGD","IE00BN8TJ469.HKD","LU0006306889.USD","LU0266013472.USD","LU0965509010.AUD","XBI","BK4533","IE00BLSP4452.SGD","LU0965509283.SGD","LU1291159041.SGD","LU1162221912.USD","BK4082","SG9999002232.USD","LU2461242641.AUD","BK4139","LU1069347547.HKD","LU1201861249.SGD","LU1934455277.USD","LU1929549753.HKD","LU2361045086.USD","SG9999015341.SGD","LU0432979614.USD","BLSX","LU0234572021.USD","IE0009355771.USD","LU1989771016.USD","LU0238689110.USD","LU0477156953.USD","SG9999015358.SGD","IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624574124","title":"Barclays Sticks to Its Buy Rating for Inventiva (IVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624574124","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624574124?lang=en_us&edition=fundamental","pubTime":"2026-04-02 16:49","pubTimestamp":1775119788,"startTime":"0","endTime":"0","summary":"Barclays analyst Eliana Merle maintained a Buy rating on Inventiva today and set a price target of $18.00. According to TipRanks, Merle is a 3-star...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-its-buy-rating-for-inventiva-iva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-its-buy-rating-for-inventiva-iva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624901535","title":"Guggenheim Keeps Their Buy Rating on Inventiva (IVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624901535","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624901535?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:17","pubTimestamp":1775042253,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Seamus Fernandez reiterated a Buy rating on Inventiva today and set a price target of $11.00. Fernandez covers the Healthcare se...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-keeps-their-buy-rating-on-inventiva-iva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-keeps-their-buy-rating-on-inventiva-iva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160010640","title":"Stock Track | Inventiva S.A. Soars 6.02% Intraday on Analyst Bullishness","url":"https://stock-news.laohu8.com/highlight/detail?id=1160010640","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160010640?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:44","pubTimestamp":1774971870,"startTime":"0","endTime":"0","summary":"Inventiva S.A. (IVA) saw its stock price surge by 6.02% during Tuesday's intraday session, reflecting significant positive investor sentiment.The sharp increase appears to be driven by recent bullish...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623535330","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2623535330","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623535330?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:30","pubTimestamp":1774971010,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Inventiva (IVA), PolyPid (PYPD) and Soligenix (SNGX)...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-84?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-84?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BLSX","BK4007","LU0029874061.USD","BK4139","BK4581","IVA","PYPD","BLSG","BK4588","BK4137","BK4112","LABU","SNGX","XBI","LU0128526141.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623533152","title":"Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), Neumora Therapeutics, Inc. (NMRA) and Gain Therapeutics (GANX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623533152","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623533152?lang=en_us&edition=fundamental","pubTime":"2026-03-31 22:50","pubTimestamp":1774968608,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Inventiva (IVA), Neumora Therapeutics, Inc. (NMRA) a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-inventiva-iva-neumora-therapeutics-inc-nmra-and-gain-therapeutics-ganx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-inventiva-iva-neumora-therapeutics-inc-nmra-and-gain-therapeutics-ganx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","XBI","XLV","BK4139","IVA","BK4007","BK4581","BK4588","BK4585","LABU","BK4137","LU0128526141.USD","GANX","NMRA","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164749330","title":"Stock Track | Inventiva Plunges 14.6% in Pre-market After Reporting Steep Revenue Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1164749330","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164749330?lang=en_us&edition=fundamental","pubTime":"2026-03-31 16:20","pubTimestamp":1774945235,"startTime":"0","endTime":"0","summary":"Inventiva S.A. (IVA) experienced a significant pre-market plunge, with shares falling 14.60%.The sharp decline follows the company's release of its 2025 financial results, which showed revenue...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623321531","title":"Inventiva 2025 Loss Narrows, Revenue Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2623321531","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623321531?lang=en_us&edition=fundamental","pubTime":"2026-03-31 04:49","pubTimestamp":1774903752,"startTime":"0","endTime":"0","summary":"Inventiva (IVA) reported a fiscal 2025 net loss late Monday of 1.90 euros ($2.18) per diluted share, narrowing from a loss of 3.08 euros a year earlier.Revenue for the year ended Dec. 31 was 4.5 million euros, down from 9.2 million euros a year earlier.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623732997","title":"Earnings Flash (IVA) Inventiva Posts 2025 Revenue 4.5 Million Euros","url":"https://stock-news.laohu8.com/highlight/detail?id=2623732997","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623732997?lang=en_us&edition=fundamental","pubTime":"2026-03-31 04:23","pubTimestamp":1774902187,"startTime":"0","endTime":"0","summary":"Earnings Flash (IVA) Inventiva Posts 2025 Revenue 4.5 Million Euros","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155846645","title":"Stock Track | Inventiva Plummets 5.77% Intraday After Missing Earnings and Sales Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=1155846645","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155846645?lang=en_us&edition=fundamental","pubTime":"2026-03-31 04:18","pubTimestamp":1774901914,"startTime":"0","endTime":"0","summary":"Inventiva S.A. (IVA) saw its stock price plummet 5.77% during intraday trading on Monday, following the release of disappointing quarterly financial results.The biopharmaceutical company reported...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["IVA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inventivapharma.com","stockEarnings":[{"period":"1week","weight":-0.0384},{"period":"1month","weight":-0.3088},{"period":"3month","weight":-0.3896},{"period":"6month","weight":-0.1416},{"period":"1year","weight":0.0821},{"period":"ytd","weight":-0.1914}],"compareEarnings":[{"period":"1week","weight":0.0211},{"period":"1month","weight":0.0212},{"period":"3month","weight":0.1253},{"period":"6month","weight":0.1243},{"period":"1year","weight":0.2644},{"period":"ytd","weight":0.1069}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of mucopolysaccharidoses type VI disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.098872},{"month":2,"riseRate":0.666667,"avgChangeRate":0.043927},{"month":3,"riseRate":0,"avgChangeRate":-0.112386},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.080671},{"month":5,"riseRate":0.5,"avgChangeRate":0.083353},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.138459},{"month":7,"riseRate":0.4,"avgChangeRate":-0.068338},{"month":8,"riseRate":0.333333,"avgChangeRate":0.149729},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.0365},{"month":10,"riseRate":0.666667,"avgChangeRate":0.071747},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.025201},{"month":12,"riseRate":0.833333,"avgChangeRate":0.034174}],"exchange":"NASDAQ","name":"Inventiva S.A.","nameEN":"Inventiva S.A.","securityTypeName":"DR","adrRate":"1:1"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inventiva S.A.(IVA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Inventiva S.A.(IVA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Inventiva S.A.,IVA,Inventiva S.A.股票,Inventiva S.A.股票老虎,Inventiva S.A.股票老虎国际,Inventiva S.A.行情,Inventiva S.A.股票行情,Inventiva S.A.股价,Inventiva S.A.股市,Inventiva S.A.股票价格,Inventiva S.A.股票交易,Inventiva S.A.股票购买,Inventiva S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inventiva S.A.(IVA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Inventiva S.A.(IVA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction